Giving statins to people who already have Alzheimer's doesn't help their memory or thinking get better.
Claim Context
Statins do not improve cognitive function in patients with existing dementia, as shown by three randomized controlled trials involving 748 patients with probable or possible Alzheimer disease followed for at least 6 months, with no significant differences in cognitive test scores between statin and placebo groups.
“No effect was found in a systematic review of 3 RCTs of statins for treatment of dementia (748 patients with a mean age of 79 years, with probable or possible Alzheimer disease, followed for 6 months or longer).”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Provide the highest-level summary of whether statins have a causal effect on cognitive outcomes in dementia patients.
A systematic review and meta-analysis of double-blind, placebo-controlled RCTs enrolling patients with mild to moderate Alzheimer disease (confirmed by biomarkers or clinical criteria), using any statin for ≥6 months, with change in ADAS-Cog or MMSE as primary outcome.
Determine if statins cause improvement in cognition in Alzheimer patients.
A double-blind RCT of 1,000 patients aged 70–90 with confirmed Alzheimer disease (via CSF biomarkers or PET), randomized to atorvastatin 80 mg/day vs placebo for 12 months, with ADAS-Cog, MMSE, and functional status as co-primary endpoints.
Show real-world associations between statin use and cognitive trajectory in dementia patients.
A prospective cohort of 10,000 dementia patients from national health databases, comparing cognitive decline rates over 3 years in those prescribed statins vs not, adjusting for baseline severity, comorbidities, and polypharmacy.